Benzinga's Top Downgrades
Analysts at Sterne Agee downgraded Cree (NASDAQ: CREE) from “buy” to “neutral.” The target price for Cree has been lowered from $66.00 to $59.00. Cree's shares closed at $61.11 yesterday.
Analysts at Jefferies downgraded Cigna (NYSE: CI) from “buy” to “hold.” The target price for Cigna has been lowered from $78.00 to $75.00. Cigna's shares closed at $69.03 yesterday.
Analysts at Stifel Nicolaus downgraded Crimson Exploration (NASDAQ: CXPO) from “buy” to “hold.” The target price for Crimson Exploration is set to $3.75. Crimson Exploration's shares closed at $3.14 yesterday.
Goldman Sachs downgraded AVG Technologies N.V. (NYSE: AVG) from “buy” to “neutral.” The target price for AVG Technologies has been raised from $18.00 to $18.50. AVG Technologies' shares closed at $17.48 yesterday.
Latest Ratings for CREE
|Oct 2016||Stephens & Co.||Downgrades||Overweight||Equal-Weight|
|Sep 2016||Williams Capital||Initiates Coverage on||Buy|
|Sep 2016||Canaccord Genuity||Assumes||Hold|
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.